Founded in 1941, Neopharm is one of the leading pharmaceutical companies in Israel. For over 75 years, we have been providing the Israeli market with a wide range of products and integrated services for patients in need with a proven track record of successful market access and launches.
Our achievements have enabled us to earn the position of partner-of-choice and all-in-house solution for multinational pharmaceuticals and biotechnology companies seeking to enter or expand their presence in Israel. We have consistently grown the value of our products, increased turnover and enhanced our market leadership in Israel.
Neopharm Israel is part of the privately owned Neopharm Group which, through its family of companies, engages in the research and development, manufacturing, marketing, sales and distribution of a broad range of products in the healthcare market in more than 60 countries worldwide. The Neopharm Group operates in three major segments: Pharmaceutical, Consumer Healthcare and Medical Devices, which together generate annual revenues exceeding four hundred million US dollars. The Group has offices in Israel, Europe, United States and employs over 900 employees worldwide.
